Skip to main content
Log in

Birth weight and risk of thyroid cancer in later life: the fetal reprogramming of miR-21 and survivin gene expression?

  • News and Views
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aarestrup J, Kitahara CM, Baker JL (2019) Birthweight and risk of thyroid cancer and its histological types: a large cohort study. Cancer Epidemiol 62:101564

    Article  Google Scholar 

  2. Li Q, Zhang S, Wang M, Dong S, Wang Y, Liu S, Lu T, Fu Y, Wang X, Chen G (2019) Downregulated miR-21 mediates matrine-induced apoptosis via the PTEN/Akt signaling pathway in FTC-133 human follicular thyroid cancer cells. Oncol Lett 18(4):3553–3560

    PubMed  PubMed Central  Google Scholar 

  3. Feng YH, Tsao CJ (2016) Emerging role of microRNA-21 in cancer. Biomed Rep 5(4):395–402

    Article  CAS  Google Scholar 

  4. Werner TA, Dizdar L, Nolten I, Riemer JC, Mersch S, Schütte SC, Driemel C, Verde PE, Raba K, Topp SA, Schott M, Knoefel WT, Krieg A (2017) Survivin and XIAP—two potential biological targets in follicular thyroid carcinoma. Sci Rep 7(1):11383

    Article  Google Scholar 

  5. Gulten T, Yakut T, Karkucak M, Baytan B, Guneş AM (2009) AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia. J Clin Lab Anal 23(6):368–371

    Article  Google Scholar 

  6. Ahmed AA, Essa MEA (2019) Potential of epigenetic events in human thyroid cancer. Cancer Genet 239:13–21

    Article  CAS  Google Scholar 

  7. Zhang JT, Cai QY, Ji SS, Zhang HX, Wang YH, Yan HT, Yang XJ (2016) Decreased miR-143 and increased miR-21 placental expression levels are associated with macrosomia. Mol Med Rep 13(4):3273–3280

    Article  CAS  Google Scholar 

  8. Lin XH, Wu DD, Gao L, Zhang JY, Pan HT, Wang H, Li C, Zhang P, Guo MX, Wu YT, Tan YJ, Jin L, Xiang YQ, Li JX, Sheng JZ, Huang HF (2016) Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children. Oncotarget 7(52):86511–86521

    PubMed  PubMed Central  Google Scholar 

  9. Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR (2019) DNA methylation-based method to differentiate malignant from benign thyroid lesions. Thyroid 29(9):1244–1254

    Article  CAS  Google Scholar 

  10. Haertle L, El Hajj N, Dittrich M, Müller T, Nanda I, Lehnen H, Haaf T (2017) Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. Clin Epigenetics 9:28

    Article  Google Scholar 

  11. Malamitsi-Puchner A, Baka S, Boutsikou M, Liosi S, Gourgiotis D, Protonotariou E, Hassiakos D, Briana DD (2009) Cord blood survivin concentrations in human full-term normal and complicated pregnancies. In Vivo 23(1):139–142

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raffaella Mormile.

Ethics declarations

Conflict of interest

The author declares no conflict of interest.

Human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mormile, R. Birth weight and risk of thyroid cancer in later life: the fetal reprogramming of miR-21 and survivin gene expression?. Arch Gynecol Obstet 301, 867–868 (2020). https://doi.org/10.1007/s00404-020-05484-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-020-05484-8

Navigation